World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
65
Citations
16385
World Ranking
2831
National Ranking
1340

Fabio Candotti publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Fabio Candotti sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 246 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Fabio Candotti D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Fabio Candotti sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 65 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Fabio Candotti is affiliated with the National Institutes of Health in the United States. Their research spans multiple disciplines, primarily focused on medicine, immunology, and microbiology, with additional work in biochemistry, genetics, and molecular biology.

Their recent publications demonstrate a strong focus on gene therapy and immunodeficiency disorders. Notable papers include:

  • Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency (2021, New England Journal of Medicine)
  • The role of B cells in COVID-19 infection and vaccination (2022, Frontiers in Immunology)
  • Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients (2021, Journal of Clinical Immunology)
  • Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency (2021, Blood)
  • Access to gene therapy for rare diseases when commercialization is not fit for purpose (2023, Nature Medicine)

Candotti frequently collaborates with other scientists, including Katerina Theodoropoulou, Isabelle Meyts, Michaël Hofer, Donald B. Kohn, and Elizabeth Garabedian.

The scientist's work has been published predominantly in venues like the Journal of Clinical Immunology, Frontiers in Immunology, Pediatric Allergy and Immunology, Revue Médicale Suisse, and Blood.

Their main fields of study cover:

  • Medicine
  • Immunology and Microbiology
  • Biochemistry, Genetics and Molecular Biology

Candotti's research areas also include several subfields of study such as:

  • Immunology
  • Genetics
  • Infectious Diseases
  • Molecular Biology
  • Physiology

Their scientific focus revolves around topics including:

  • Immunodeficiency and Autoimmune Disorders
  • Virus-based gene therapy research
  • T-cell and B-cell Immunology
  • Immune Cell Function and Interaction
  • Parvovirus B19 Infection Studies
  • Adenosine and Purinergic Signaling
  • Cytomegalovirus and herpesvirus research

Best Publications

  • Activated STING in a Vascular and Pulmonary Syndrome

    Y. Liu;A.A. Jesus;B. Marrero;D. Yang

  • Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID).

    P Macchi;A Villa;S Giliani;M G Sacco

  • Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing

    Michael R. Wilson;Samia N. Naccache;Erik Samayoa;Mark Biagtan

  • Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2

    Qing Zhou;Dan Yang;Amanda K Ombrello;Andrey V Zavialov

  • Engraftment potential of human amnion and chorion cells derived from term placenta

    Marco Bailo;Maddalena Soncini;Elsa Vertua;Patrizia Bonassi Signoroni

  • The altered landscape of the human skin microbiome in patients with primary immunodeficiencies

    Julia Oh;Alexandra F. Freeman;Nisc Comparative Sequencing Program;Morgan Park

  • Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial.

    Linda Mesler Muul;Laura M. Tuschong;Sherry Lau Soenen;G. Jayashree Jagadeesh

  • Gene therapy for adenosine deaminase–deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans

    Fabio Candotti;Kit L. Shaw;Linda Muul;Denise Carbonaro

  • How I treat ADA deficiency

    H. Bobby Gaspar;Alessandro Aiuti;Fulvio Porta;Fabio Candotti

  • Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy.

    Laura Tuschong;Sherry L. Soenen;R. Michael Blaese;Fabio Candotti

  • Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness

    Chantal Lagresle-Peyrou;Chantal Lagresle-Peyrou;Chantal Lagresle-Peyrou;Emmanuelle M Six;Emmanuelle M Six;Capucine Picard;Frédéric Rieux-Laucat;Frédéric Rieux-Laucat

  • Somatic mosaicism in Wiskott–Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism

    Taizo Wada;Shepherd H. Schurman;Makoto Otsu;Elizabeth K. Garabedian

  • Mutation Analysis of IL2RG in Human X-Linked Severe Combined Immunodeficiency

    Jennifer M. Puck;Amy E. Pepper;Paula S. Henthorn;Fabio Candotti

  • Structural and functional basis for JAK3-deficient severe combined immunodeficiency.

    Fabio Candotti;Scott A. Oakes;James A. Johnston;Silvia Giliani

  • Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.

    Fabio Candotti

  • Gene therapy: X-SCID transgene leukaemogenicity.

    Adrian J. Thrasher;Adrian J. Thrasher;H. Bobby Gaspar;H. Bobby Gaspar;Christopher Baum;Christopher Baum;Ute Modlich

  • Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.

    Donald B. Kohn;Claire Booth;Kit L. Shaw;Jinhua Xu-Bayford

  • Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs.

    Marko Pesu;Fabio Candotti;Matthew Husa;Sigrun R. Hofmann

  • Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: Evidence for interactions between the kinase and pseudokinase domains

    Min Chen;Alan Cheng;Fabio Candotti;Yong Jie Zhou

  • American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells.

    Donald B. Kohn;Michel Sadelain;Cynthia Dunbar;David Bodine

  • A novel form of complete IL-12/IL-23 receptor β1 deficiency with cell surface-expressed nonfunctional receptors

    Claire Fieschi;Marita Bosticardo;Ludovic De Beaucoudrey;Stéphanie Boisson-Dupuis

  • Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways.

    Scott A. Oakes;Scott A. Oakes;Fabio Candotti;James A. Johnston;Yi-Qing Chen

Frequent Co-Authors

Donald B. Kohn
Donald B. Kohn University of California, Los Angeles
Luigi D. Notarangelo
Luigi D. Notarangelo National Institutes of Health
John J. O'Shea
John J. O'Shea National Institutes of Health
Michael S. Hershfield
Michael S. Hershfield Duke University
Adrian J. Thrasher
Adrian J. Thrasher University College London
R. Michael Blaese
R. Michael Blaese National Institutes of Health
Anna Villa
Anna Villa National Academies of Sciences, Engineering, and Medicine
Silvia Giliani
Silvia Giliani University of Brescia
Rebecca H. Buckley
Rebecca H. Buckley Duke University
Jennifer M. Puck
Jennifer M. Puck University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related online degrees can open diverse career opportunities in healthcare and research. Nursing pathways, in particular, complement immunology expertise by focusing on patient care and healthcare delivery.

Many students consider accelerated programs to advance quickly into nursing roles. Options like accelerated FNP programs allow aspiring nurses to become family nurse practitioners faster, blending clinical skills with advanced knowledge.

For individuals new to healthcare, online accelerated nursing programs for non nurses provide a streamlined path into nursing without prior experience. These programs balance convenience with comprehensive training.

If you are seeking a more accessible entry point, identifying the easiest ABSN program to get into can be beneficial. These programs often have flexible admission standards, helping students start their nursing careers sooner.

Additionally, for those looking at practical nursing roles, choosing from LPN programs with easiest admission requirements can simplify the entry process while gaining essential skills to work closely with patients and support healthcare teams.

Best Scientists Citing Fabio Candotti

Trending Scientists

Recently Published Articles